---
$id: https://graph.org.ai/products/commodity/51343118
$type: Product
source: UNSPSC
code: "51343118"
title: "Lamivudine sulfoxide"
class: "51343100"
classTitle: "Antiviral pyrimidines"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lamivudine sulfoxide

**UNSPSC Code**: 51343118
**Class**: [Antiviral pyrimidines](Antiviral pyrimidines.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a reverse transcriptase inhibitor with the molecular formula C8H11N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier L0EH965X85, chemically known as lamivudine sulfoxide, (3rs)-, but more generally known as lamivudine sulfoxide, which bears US NIH Compound Identifier 3081342. European Medicines Agency schedules lamivudine sulfoxide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08392MIG. Most nations, for tariff purposes, schedule lamivudine sulfoxide under HS 29349990. SMILES: C1CN(C(=O)NC1N)[C@@H]2C[S+]([C@@H](O2)CO)[O-].

